# Trellis Bioscience, Inc.: Form D capital raise (Redwood City, CA)

**Vendor Spend Propensity Score (CPA / Tax / Audit):** 70/100
**Estimated post-raise budget for this service type:** $181,860 (heuristic)

| Field | Value |
|---|---|
| Industry | Biotechnology (Healthcare & Life Sciences) |
| Operating company | Yes |
| Exemption | 506(b) |
| Amount sold | $9,093,000 |
| Total offering | Indefinite / n/a |
| Investors so far | 16 |
| First sale | 2026-01-30 |
| Filed | 2026-10-29 (amendment) |
| Entity | Corporation |

## Executives and related persons (as listed in the filing)
- Nora Mende: Executive Officer
- Larry Kauvar: Executive Officer

## Why this score
- Operating company: new capital typically funds hiring, facilities and vendors.
- Raised $9,093,000 so far.
- Healthcare & Life Sciences companies are a strong fit for CPA / Tax / Audit services.
- Filed 6 days ago.

Source: SEC EDGAR Form D filings (U.S. Securities and Exchange Commission) (https://www.sec.gov/Archives/edgar/data/1162015/000092963826004073/). Last refreshed: 2026-11-04T09:16:10.755Z.
Informational only. SEC EDGAR Form D data is shown for business-development research; it is not investment advice and not an offer or solicitation to buy or sell any security. Not legal or financial advice.